Mizuho Medy Co Ltd
TSE:4595
Operating Margin
Mizuho Medy Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| JP |
|
Mizuho Medy Co Ltd
TSE:4595
|
34.4B JPY |
43%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
226.9B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
151.6B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140.9B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.9B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.4B EUR |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD |
14%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.5B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
261.7B CNY |
36%
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Mizuho Medy Co Ltd's most recent financial statements, the company has Operating Margin of 43%.
You don't have any saved screeners yet